SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-011636
Filing Date
2023-04-03
Accepted
2023-04-03 17:17:25
Documents
14
Period of Report
2023-04-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-20230403.htm   iXBRL 8-K 64851
2 EX-99.1 vktx-ex99_1.htm EX-99 20896
3 GRAPHIC img201808844_0.jpg GRAPHIC 13142
  Complete submission text file 0000950170-23-011636.txt   232640

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vktx-20230403_pre.xml EX-101.PRE 11130
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vktx-20230403_lab.xml EX-101.LAB 17757
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vktx-20230403.xsd EX-101.SCH 2492
8 EXTRACTED XBRL INSTANCE DOCUMENT vktx-20230403_htm.xml XML 4719
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 23793894
SIC: 2834 Pharmaceutical Preparations